Works matching IS 2050-6511 AND VI 26 AND IP 1 AND DT 2025
Results: 74
A retrospective research of adverse event reporting system events for voxelotor based on the FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00915-1
- By:
- Publication type:
- Article
Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00912-4
- By:
- Publication type:
- Article
Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00911-5
- By:
- Publication type:
- Article
Protective effects of lipid emulsion on vital organs through the LPS/TLR4 pathway in acute organophosphate poisoning.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00904-4
- By:
- Publication type:
- Article
AMD1, a cardiotoxicity target for Maduramicin.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00897-0
- By:
- Publication type:
- Article
Post-market safety profile of cefiderocol: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS).
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00894-3
- By:
- Publication type:
- Article
Post-marketing safety of elacestrant in breast cancer: a pharmacovigilance investigation using the FDA adverse event reporting system.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00887-2
- By:
- Publication type:
- Article
Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00886-3
- By:
- Publication type:
- Article
Effects of different antiplatelet therapy drugs on platelet activation and platelet-leukocyte aggregate formation in early septic ARDS.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-024-00806-x
- By:
- Publication type:
- Article
Mitigating hepatic ischemia and reperfusion injury with polyethylene glycol-enriched Ringer's lactate fluid: insights from an isolated perfused rat model.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00835-0
- By:
- Publication type:
- Article
Can quercetin reduce arsenic induced toxicity in mouse BALB/c 3T3 fibroblast cells? A study involving in vitro, molecular docking, and ADME predictions.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00906-2
- By:
- Publication type:
- Article
Effects of adenosine triphosphate, thiamine pyrophosphate, melatonin, and liv-52 on subacute pyrazinamide proliferation hepatotoxicity in rats.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00901-7
- By:
- Publication type:
- Article
Combination of 10-hydroxy-decanoic acid and ZnO nanoparticles abrogates lead acetate-induced nephrotoxicity in rats: targeting oxidative stress and inflammatory signalling.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00888-1
- By:
- Publication type:
- Article
Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013–2022).
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00905-3
- By:
- Publication type:
- Article
Development and validation of potential molecular subtypes and signatures of thyroid eye disease based on angiogenesis-related gene analysis.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00880-9
- By:
- Publication type:
- Article
Oxidative stress and anti-oxidant status in children with sepsis.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00895-2
- By:
- Publication type:
- Article
Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00884-5
- By:
- Publication type:
- Article
A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS).
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00890-7
- By:
- Publication type:
- Article
A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00896-1
- By:
- Publication type:
- Article
A new RP-HPLC approach for estimation of potential impurities of Fosamprenavir - method development and validation.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00892-5
- By:
- Publication type:
- Article
Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance study.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00859-6
- By:
- Publication type:
- Article
Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00898-z
- By:
- Publication type:
- Article
Therapeutic role of melatonin on acrylamide-induced neurotoxicity via reducing ER stress, inflammation, and apoptosis in a rat model.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00900-8
- By:
- Publication type:
- Article
Correction: Aspirin plus clopidogrel versus cilostazol -based triple antiplatelet therapy in patients with ischemic heart disease undergoing PCI: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
A disproportionality analysis of real-world events from the FDA Adverse Event Reporting System (FAERS) for Atezolizumab.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00879-2
- By:
- Publication type:
- Article
Computational study on the mechanism of small molecules inhibiting NLRP3 with ensemble docking and molecular dynamic simulations.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00851-0
- By:
- Publication type:
- Article
Development of nanospray loaded with ciclopirox for dermal fungus treatment: determination of pro-inflammatory interleukin IL-2 mRNA expression.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00853-y
- By:
- Publication type:
- Article
Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00873-8
- By:
- Publication type:
- Article
Risk of drug-induced pericardial effusion: a disproportionality analysis of the FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00867-6
- By:
- Publication type:
- Article
Gastrointestinal toxicity of antibody–drug conjugates: a pharmacovigilance study using the FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00877-4
- By:
- Publication type:
- Article
A comparative study of using scorpion antivenom versus scorpion antivenom and prazosin drug for scorpion stings management in Sohag University Hospitals.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00854-x
- By:
- Publication type:
- Article
Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00878-3
- By:
- Publication type:
- Article
Prodelphinidin B-2,3,3"-O-gallate via chemical oxidation of epigallocatechin-3-gallate shows high efficacy inhibiting triple-negative breast cancer cells.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00883-6
- By:
- Publication type:
- Article
Past use of metformin is associated with increased risk of myelodysplastic syndrome development in diabetes mellitus patients: a cross-sectional study of 54,869 patients.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00882-7
- By:
- Publication type:
- Article
Development and validation of a nomogram to predict linezolid-induced thrombocytopenia in hospitalized adults.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00874-7
- By:
- Publication type:
- Article
Melatonin protect against pregabalin-induced gonadotoxicity via anti-oxidative, anti-inflammatory, anti-apoptotic, enzymatic and hormonal regulatory mechanisms in rats.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00863-w
- By:
- Publication type:
- Article
Assessment the real-world safety of intravitreal dexamethasone implant (Ozurdex): novel insights from a comprehensive pharmacovigilance analysis utilizing the FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00866-7
- By:
- Publication type:
- Article
Correction: Effects of cypermethrin exposure on learning and memory functions and anxiety-like behavior in rats.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-024-00832-9
- By:
- Publication type:
- Article
Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00872-9
- By:
- Publication type:
- Article
Neuroprotective effects of berberine in preclinical models of ischemic stroke: a systematic review.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00843-0
- By:
- Publication type:
- Article
Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00871-w
- By:
- Publication type:
- Article
Aspirin plus clopidogrel versus cilostazol -based triple antiplatelet therapy in patients with ischemic heart disease undergoing PCI: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00870-x
- By:
- Publication type:
- Article
A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS).
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00869-4
- By:
- Publication type:
- Article
Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00868-5
- By:
- Publication type:
- Article
The therapeutics effects of monobenazone on treatment of psoriasis induced in mice.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00848-9
- By:
- Publication type:
- Article
Food effects and pharmacokinetic evaluation of oral single-dose prednisone acetate and prednisolone in healthy Chinese subjects.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00865-8
- By:
- Publication type:
- Article
Identification of benzo(a)pyrene-related toxicological targets and their role in chronic obstructive pulmonary disease pathogenesis: a comprehensive bioinformatics and machine learning approach.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00842-1
- By:
- Publication type:
- Article
The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00861-y
- By:
- Publication type:
- Article
Intratympanic N-acetylcysteine in the prevention of cisplatin-induced ototoxicity: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-024-00829-4
- By:
- Publication type:
- Article